The trademark application QELLD was filed by Bayer Aktiengesellschaft, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 22, 2022, and it was registered by office on June 29, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1676710 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on April 5, 2022. Partial Surrender of the trademark registration was recorded on February 26, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for humans namely treatment of gynecological related diseases, disorders and deficiencies
Pharmaceutical preparations for humans namely treatment of hormone related diseases, disorders and deficiencies
Pharmaceutical preparations for humans namely treatment of cardiological related diseases, disorders and deficiencies
Pharmaceutical preparations for humans namely treatment of oncological related diseases, disorders and deficiencies
Excluding preparations for the treatment of autoimmune and inflammatory diseases, disorders and deficiencies
And excluding preparations for preventing organ transplant rejection.